Key Events This Week
11 May: MarketsMOJO downgrades RPG Life Sciences Ltd to Sell amid technical and financial concerns
12 May: Technical momentum shifts to sideways trend with mixed indicator signals
15 May: Week closes at Rs.2,295.65, down 6.64% for the week

MarketsMOJO Downgrades RPG Life Sciences Ltd to Sell Amid Technical and Financial Concerns
2026-05-12 08:40:49RPG Life Sciences Ltd has seen its investment rating downgraded from Hold to Sell as of 11 May 2026, reflecting a combination of deteriorating technical indicators, flat recent financial performance, and valuation concerns. Despite a strong long-term return record, the company’s current outlook is clouded by sideways technical trends and subdued quarterly results, prompting a reassessment of its investment appeal.
Read full news article
RPG Life Sciences Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals
2026-05-12 08:03:11RPG Life Sciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock exhibits a complex interplay of technical indicators that suggest cautious investor sentiment amid volatile price action.
Read full news articleRPG Life Sciences Gains 1.45%: Mixed Technical Signals and Rating Upgrade Shape the Week
2026-05-09 17:10:54
Key Events This Week
4 May: Week opens at Rs.2,423.80
5 May: Sharp 4.26% decline amid mixed technical signals
6 May: Upgrade to Hold rating by MarketsMOJO; technical momentum shifts
7 May: Strong rebound with 3.98% gain
8 May: Week closes at Rs.2,458.95, up 1.45% for the week

RPG Life Sciences Ltd Upgraded to Hold as Financial and Technical Trends Shift
2026-05-06 08:19:51RPG Life Sciences Ltd has seen its investment rating upgraded from Sell to Hold as of 5 May 2026, reflecting a nuanced shift in its financial performance, valuation metrics, and technical indicators. Despite some challenges, the company’s improved quarterly profits, cash reserves, and mildly bullish technical signals have contributed to this reassessment, signalling cautious optimism for investors in the pharmaceuticals and biotechnology sector.
Read full news articleRPG Life Sciences Limited - Other General Purpose
28-Nov-2019 | Source : NSERPG Life Sciences Limited has submitted to the Exchange a copy of disclosure of Related Party Transactions for the half year ended September 30, 2019.
RPG Life Sciences Limited - Updates
01-Nov-2019 | Source : NSERPG Life Sciences Limited has informed the Exchange regarding 'In terms of the Regulation 30 read with Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the newspaper publications with respect to Unaudited Financial Results for the quarter and half year ended September 30, 2019.
RPG Life Sciences Limited - Outcome of Board Meeting
31-Oct-2019 | Source : NSERPG Life Sciences Limited has informed the Exchange regarding Board meeting held on October 30, 2019.
Corporate Actions
No Upcoming Board Meetings
RPG Life Sciences Ltd has declared 250% dividend, ex-date: 27 Jun 25
No Splits history available
No Bonus history available
No Rights history available










